Forschung & Innovation
Publikationen
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
PMU Autor*innen
Romana Wass, Brane Grambozov, Felix Sedlmayer, Michael Studnicka, Franz Zehentmayr
Alle Autor*innen
Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr
Fachzeitschrift
Cancers
Kurzfassung
Keywords
SURVIVAL, RADIOTHERAPY, CONSOLIDATION, CHEMORADIATION, PHASE-III, CELL LUNG-CANCER, CONCURRENT, INHIBITOR-RELATED PNEUMONITIS, REAL-WORLD DATA, RTOG 0617